ZA9710632B - New polymorphic form of doxazosin mesylate (form 1) - Google Patents
New polymorphic form of doxazosin mesylate (form 1)Info
- Publication number
- ZA9710632B ZA9710632B ZA9710632A ZA9710632A ZA9710632B ZA 9710632 B ZA9710632 B ZA 9710632B ZA 9710632 A ZA9710632 A ZA 9710632A ZA 9710632 A ZA9710632 A ZA 9710632A ZA 9710632 B ZA9710632 B ZA 9710632B
- Authority
- ZA
- South Africa
- Prior art keywords
- doxazosin mesylate
- new polymorphic
- polymorphic form
- new
- doxazosin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96120601A EP0849264A1 (de) | 1996-12-20 | 1996-12-20 | Neue polymorphe Form von doxazosinmesylat (Form I) |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9710632B true ZA9710632B (en) | 1998-11-11 |
Family
ID=8223529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9710632A ZA9710632B (en) | 1996-12-20 | 1997-01-01 | New polymorphic form of doxazosin mesylate (form 1) |
Country Status (10)
Country | Link |
---|---|
US (1) | US6130218A (xx) |
EP (1) | EP0849264A1 (xx) |
JP (1) | JPH10182639A (xx) |
KR (1) | KR19980064286A (xx) |
CA (1) | CA2224916A1 (xx) |
HU (1) | HUP9702480A3 (xx) |
IL (1) | IL122420A (xx) |
NZ (1) | NZ329404A (xx) |
TW (1) | TW420678B (xx) |
ZA (1) | ZA9710632B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19800214A1 (de) * | 1998-01-06 | 1999-07-15 | Knoll Ag | Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür |
US6706721B1 (en) * | 1998-04-29 | 2004-03-16 | Osi Pharmaceuticals, Inc. | N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
ES2164520B1 (es) * | 1999-03-16 | 2003-04-01 | Medichem Sa | "procedimiento de obtencion del polimorfo a del mesilato de doxazosina" |
DE19912573A1 (de) * | 1999-03-19 | 2000-09-21 | Knoll Ag | Arzneimittel, enthaltend Doxazosin-Mesylat der Kristallmodifikaton D |
UA74803C2 (uk) * | 1999-11-11 | 2006-02-15 | Осі Фармасьютікалз, Інк. | Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування |
US7087613B2 (en) * | 1999-11-11 | 2006-08-08 | Osi Pharmaceuticals, Inc. | Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride |
JP2011507938A (ja) | 2007-12-24 | 2011-03-10 | シプラ・リミテッド | メシル酸ドキサゾシンの結晶多形(形態iv)及びその製造方法 |
CN109988158A (zh) * | 2018-01-03 | 2019-07-09 | 合肥立方制药股份有限公司 | X晶型、含有x晶型的多沙唑嗪甲磺酸盐及其制备方法和用途 |
KR20190119416A (ko) | 2018-04-12 | 2019-10-22 | 조선대학교산학협력단 | 다이빙 후드 |
CN111303130B (zh) * | 2018-12-11 | 2021-09-14 | 合肥立方制药股份有限公司 | 一种多沙唑嗪甲磺酸盐晶型、其制备方法及用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2699054A (en) * | 1953-10-09 | 1955-01-11 | Lloyd H Conover | Tetracycline |
US4092315A (en) * | 1976-03-01 | 1978-05-30 | Pfizer Inc. | Novel crystalline forms of prazosin hydrochloride |
GB1591490A (en) * | 1977-08-04 | 1981-06-24 | Abbott Lab | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate |
US4188390A (en) | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
DK154082C (da) * | 1977-11-05 | 1989-02-27 | Pfizer | Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf |
DE3683760D1 (de) * | 1986-03-21 | 1992-03-12 | Heumann Pharma Gmbh & Co | Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung. |
EP0459666B1 (en) * | 1990-05-31 | 1994-11-09 | Pfizer Inc. | Medicaments against impotence |
AU5457694A (en) * | 1992-11-04 | 1994-05-24 | Sepracor, Inc. | Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
US5294615A (en) * | 1993-04-29 | 1994-03-15 | Abbott Laboratories | Terazosin polymorph and pharmaceutical composition |
US5412095A (en) * | 1993-04-29 | 1995-05-02 | Abbott Laboratories | Terazosin monohydrochloride and processes and intermediate for its production |
US5504207A (en) * | 1994-10-18 | 1996-04-02 | Abbott Laboratories | Process and intermediate for the preparation of terazosin hydrochloride dihydrate |
-
1996
- 1996-12-20 EP EP96120601A patent/EP0849264A1/de not_active Withdrawn
-
1997
- 1997-01-01 ZA ZA9710632A patent/ZA9710632B/xx unknown
- 1997-12-02 IL IL12242097A patent/IL122420A/xx not_active IP Right Cessation
- 1997-12-03 TW TW086118163A patent/TW420678B/zh active
- 1997-12-16 NZ NZ329404A patent/NZ329404A/xx not_active IP Right Cessation
- 1997-12-16 HU HU9702480A patent/HUP9702480A3/hu unknown
- 1997-12-16 CA CA002224916A patent/CA2224916A1/en not_active Abandoned
- 1997-12-17 JP JP9364069A patent/JPH10182639A/ja active Pending
- 1997-12-17 US US08/992,252 patent/US6130218A/en not_active Expired - Lifetime
- 1997-12-17 KR KR1019970070177A patent/KR19980064286A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL122420A (en) | 2000-06-01 |
HUP9702480A2 (hu) | 1999-04-28 |
IL122420A0 (en) | 1998-06-15 |
HU9702480D0 (en) | 1998-03-02 |
CA2224916A1 (en) | 1998-06-20 |
KR19980064286A (ko) | 1998-10-07 |
HUP9702480A3 (en) | 1999-06-28 |
AU4690497A (en) | 1998-06-25 |
EP0849264A1 (de) | 1998-06-24 |
NZ329404A (en) | 1999-02-25 |
JPH10182639A (ja) | 1998-07-07 |
AU720753B2 (en) | 2000-06-08 |
US6130218A (en) | 2000-10-10 |
TW420678B (en) | 2001-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL330753A1 (en) | Method of obtaining 2,3-dihalogenopropanols | |
ZA9710632B (en) | New polymorphic form of doxazosin mesylate (form 1) | |
PL327733A1 (en) | Method of obtaining polyethylene (2,6-naphtalate) | |
PL330400A1 (en) | Method of obtaining azacyclohexapeptides | |
IL122631A0 (en) | New polymorphic form of doxazosin mesylate (form II) | |
PL331899A1 (en) | Method of obtaining bis-indolyl malimides | |
PL328571A1 (en) | Methods of obtaining biphenylisoxazol sulphonamides | |
IL135711A0 (en) | Novel polymorphic forms of cipamfylline | |
PL332141A1 (en) | Method of obtaining fluoxetin | |
AU720753C (en) | New polymorphic form of doxazosin mesylate (Form I) | |
PL320529A1 (en) | Apparatus for combined drilling of blast-holes and anchor-holes | |
GB9619402D0 (en) | Screening of enclosures | |
PL334066A1 (en) | Oily composition of dihydropolyprenoles | |
CA83885S (en) | Set of screens | |
TW298062U (en) | Improvement of slowly-descending escape apparatus | |
TW294983U (en) | Structure of auto-adjustable drilling machine | |
TW399399U (en) | Improved structure of leveling apparatus | |
PL332941A1 (en) | Method of obtaining naphtyridinic compounds and novel intermediate compounds | |
TW300446U (en) | Improved structure of back-patting apparatus | |
TW306561U (en) | Improved structure of wind-stopping block | |
TW358610U (en) | Improvement of inter-com | |
TW303899U (en) | Improved fastening structure of template (1) | |
PL336473A1 (en) | Method of obtaining 1,4,7,10-tetrazacyclodekane | |
TW315731U (en) | Improved structure of fitness equipment | |
PL303736A1 (en) | Method of obtaining 2,4,6-trichloroaminobenzene |